Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
In Situ Hybridization, Fluorescence | 41 | 2020 | 2521 | 1.280 |
Why?
|
Chromosome Aberrations | 15 | 2022 | 1778 | 1.010 |
Why?
|
Comparative Genomic Hybridization | 14 | 2017 | 474 | 0.780 |
Why?
|
DNA Copy Number Variations | 11 | 2020 | 2048 | 0.720 |
Why?
|
Brain Neoplasms | 24 | 2025 | 9118 | 0.710 |
Why?
|
Cytogenetic Analysis | 5 | 2016 | 271 | 0.710 |
Why?
|
Glioma | 14 | 2025 | 3503 | 0.600 |
Why?
|
Chromosome Banding | 6 | 2016 | 261 | 0.590 |
Why?
|
Meningioma | 7 | 2024 | 1220 | 0.570 |
Why?
|
Meningeal Neoplasms | 7 | 2024 | 1253 | 0.550 |
Why?
|
Leiomyoma | 8 | 2003 | 644 | 0.550 |
Why?
|
Central Nervous System Neoplasms | 3 | 2020 | 928 | 0.530 |
Why?
|
Chromosome Deletion | 9 | 2015 | 1385 | 0.520 |
Why?
|
Abnormalities, Multiple | 6 | 2011 | 1424 | 0.510 |
Why?
|
Glioblastoma | 12 | 2023 | 3464 | 0.490 |
Why?
|
Hodgkin Disease | 6 | 2019 | 1384 | 0.480 |
Why?
|
Uterine Neoplasms | 8 | 2003 | 1424 | 0.420 |
Why?
|
Chromosomes, Human, Pair 9 | 5 | 2019 | 534 | 0.410 |
Why?
|
Translocation, Genetic | 7 | 2015 | 1394 | 0.410 |
Why?
|
Optic Nerve Glioma | 3 | 2021 | 32 | 0.410 |
Why?
|
Lipoma | 4 | 2017 | 296 | 0.400 |
Why?
|
High-Throughput Nucleotide Sequencing | 12 | 2020 | 3671 | 0.390 |
Why?
|
Cystadenocarcinoma, Serous | 4 | 2024 | 480 | 0.390 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2021 | 1613 | 0.390 |
Why?
|
DNA Fragmentation | 1 | 2012 | 240 | 0.390 |
Why?
|
Chromosomes, Human, Pair 5 | 3 | 2014 | 387 | 0.380 |
Why?
|
Chromosome Disorders | 2 | 2011 | 498 | 0.380 |
Why?
|
Cytogenetics | 2 | 2016 | 198 | 0.380 |
Why?
|
Genomics | 7 | 2021 | 5926 | 0.350 |
Why?
|
Gene Amplification | 7 | 2020 | 1095 | 0.330 |
Why?
|
Astrocytoma | 5 | 2014 | 774 | 0.330 |
Why?
|
Karyotyping | 9 | 2022 | 1177 | 0.320 |
Why?
|
Chromosomes, Human, Pair 12 | 5 | 2004 | 432 | 0.310 |
Why?
|
Prenatal Diagnosis | 2 | 2016 | 1275 | 0.300 |
Why?
|
Gene Expression Regulation, Neoplastic | 16 | 2016 | 8647 | 0.300 |
Why?
|
Medical Oncology | 1 | 2020 | 2346 | 0.300 |
Why?
|
HMGA2 Protein | 3 | 2004 | 101 | 0.290 |
Why?
|
Crying | 1 | 2007 | 37 | 0.290 |
Why?
|
Synaptotagmins | 1 | 2007 | 53 | 0.280 |
Why?
|
Gene Dosage | 9 | 2020 | 1219 | 0.280 |
Why?
|
Fallopian Tube Neoplasms | 2 | 2024 | 329 | 0.280 |
Why?
|
Neoplasm Recurrence, Local | 11 | 2022 | 9419 | 0.270 |
Why?
|
Chromosomes, Human, Pair 10 | 5 | 2001 | 275 | 0.270 |
Why?
|
Isochromosomes | 1 | 2005 | 16 | 0.260 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2011 | 595 | 0.250 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2005 | 127 | 0.250 |
Why?
|
Clinical Laboratory Techniques | 1 | 2010 | 747 | 0.240 |
Why?
|
Chromosomes, Human, Pair 1 | 5 | 2014 | 640 | 0.230 |
Why?
|
Morpholines | 2 | 2019 | 584 | 0.230 |
Why?
|
Cerebellar Neoplasms | 2 | 2010 | 591 | 0.230 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 3 | 2021 | 1437 | 0.230 |
Why?
|
Mutation | 24 | 2025 | 30238 | 0.230 |
Why?
|
Proto-Oncogene Proteins B-raf | 6 | 2019 | 2059 | 0.220 |
Why?
|
Polyploidy | 1 | 2024 | 120 | 0.220 |
Why?
|
Aminopyridines | 2 | 2019 | 580 | 0.220 |
Why?
|
Neoplasm Proteins | 5 | 2020 | 3603 | 0.210 |
Why?
|
Genetic Testing | 2 | 2014 | 3591 | 0.190 |
Why?
|
Gene Deletion | 5 | 2002 | 2675 | 0.190 |
Why?
|
Gene Fusion | 2 | 2016 | 356 | 0.190 |
Why?
|
Lymphoma, B-Cell | 2 | 2019 | 945 | 0.190 |
Why?
|
Humans | 116 | 2025 | 768166 | 0.180 |
Why?
|
Genes, Tumor Suppressor | 4 | 1998 | 1062 | 0.180 |
Why?
|
Neurofibromatosis 1 | 3 | 2021 | 561 | 0.180 |
Why?
|
Histiocytes | 1 | 2021 | 97 | 0.180 |
Why?
|
Oligodendroglioma | 2 | 2014 | 274 | 0.180 |
Why?
|
Immunohistochemistry | 17 | 2020 | 11095 | 0.180 |
Why?
|
Genetic Diseases, Inborn | 2 | 2004 | 606 | 0.180 |
Why?
|
Receptor, erbB-2 | 3 | 2020 | 2603 | 0.180 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2015 | 2846 | 0.180 |
Why?
|
Antibodies, Monoclonal | 4 | 2020 | 9263 | 0.170 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 1998 | 411 | 0.170 |
Why?
|
Phenotype | 9 | 2020 | 16726 | 0.170 |
Why?
|
Soft Tissue Neoplasms | 2 | 2020 | 1164 | 0.170 |
Why?
|
Receptor, trkB | 1 | 2020 | 124 | 0.170 |
Why?
|
DNA Mutational Analysis | 8 | 2016 | 4120 | 0.170 |
Why?
|
Abortion, Spontaneous | 2 | 2022 | 535 | 0.170 |
Why?
|
Prognosis | 14 | 2025 | 30010 | 0.160 |
Why?
|
Ovarian Neoplasms | 4 | 2024 | 4916 | 0.160 |
Why?
|
beta 2-Microglobulin | 2 | 2018 | 330 | 0.160 |
Why?
|
Mediastinal Neoplasms | 2 | 2019 | 403 | 0.160 |
Why?
|
Oncogene Proteins | 3 | 2013 | 717 | 0.160 |
Why?
|
Genetics, Medical | 1 | 2021 | 334 | 0.160 |
Why?
|
Sarcoma, Synovial | 1 | 2020 | 156 | 0.160 |
Why?
|
Chromosome Breakage | 3 | 2008 | 159 | 0.160 |
Why?
|
Neurilemmoma | 1 | 2024 | 522 | 0.160 |
Why?
|
Repressor Proteins | 3 | 2020 | 2982 | 0.150 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2020 | 195 | 0.150 |
Why?
|
Transcription Factor RelA | 1 | 2019 | 252 | 0.150 |
Why?
|
Supratentorial Neoplasms | 1 | 2019 | 156 | 0.150 |
Why?
|
Exostoses, Multiple Hereditary | 1 | 1998 | 29 | 0.150 |
Why?
|
Female | 65 | 2025 | 397192 | 0.150 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2019 | 125 | 0.150 |
Why?
|
Tumor Escape | 1 | 2021 | 372 | 0.150 |
Why?
|
Benzimidazoles | 2 | 2021 | 864 | 0.140 |
Why?
|
Blotting, Northern | 4 | 2010 | 1550 | 0.140 |
Why?
|
Neoplasm Staging | 10 | 2019 | 11244 | 0.140 |
Why?
|
Peritoneal Neoplasms | 1 | 2024 | 714 | 0.140 |
Why?
|
Infratentorial Neoplasms | 1 | 2018 | 99 | 0.140 |
Why?
|
Myelodysplastic Syndromes | 2 | 2005 | 1399 | 0.140 |
Why?
|
Chromosomes, Human, Pair 6 | 6 | 2013 | 370 | 0.140 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2000 | 271 | 0.140 |
Why?
|
NF-kappa B | 2 | 2019 | 2493 | 0.140 |
Why?
|
Antineoplastic Agents | 5 | 2019 | 13676 | 0.140 |
Why?
|
Genome, Human | 6 | 2020 | 4446 | 0.140 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 1998 | 167 | 0.140 |
Why?
|
Male | 57 | 2025 | 364719 | 0.140 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2018 | 1441 | 0.130 |
Why?
|
Fallopian Tubes | 2 | 2013 | 179 | 0.130 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2016 | 42 | 0.130 |
Why?
|
Ependymoma | 1 | 2019 | 328 | 0.130 |
Why?
|
Oncogene Proteins v-myb | 1 | 2016 | 26 | 0.130 |
Why?
|
Imidazolines | 1 | 2015 | 18 | 0.130 |
Why?
|
Chromosomes, Human, Pair 7 | 5 | 2008 | 310 | 0.130 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2007 | 323 | 0.130 |
Why?
|
Precancerous Conditions | 1 | 2022 | 985 | 0.130 |
Why?
|
STAT6 Transcription Factor | 1 | 2016 | 196 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 3 | 2020 | 4528 | 0.130 |
Why?
|
Retinoblastoma | 1 | 2018 | 321 | 0.120 |
Why?
|
Developmental Disabilities | 3 | 2008 | 1518 | 0.120 |
Why?
|
Pinealoma | 1 | 2015 | 52 | 0.120 |
Why?
|
Sequence Analysis, DNA | 8 | 2020 | 4786 | 0.120 |
Why?
|
Rhabdoid Tumor | 1 | 2017 | 211 | 0.120 |
Why?
|
Glycoproteins | 1 | 2002 | 2202 | 0.120 |
Why?
|
Proteins | 3 | 2019 | 6009 | 0.120 |
Why?
|
Heterozygote | 2 | 2008 | 2798 | 0.120 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2015 | 2954 | 0.120 |
Why?
|
Chromosomes, Human | 1 | 2016 | 438 | 0.120 |
Why?
|
Carcinoma | 2 | 2020 | 2332 | 0.120 |
Why?
|
Optic Nerve Neoplasms | 1 | 2014 | 45 | 0.120 |
Why?
|
Gene Expression Profiling | 9 | 2016 | 9538 | 0.110 |
Why?
|
Medulloblastoma | 2 | 2010 | 683 | 0.110 |
Why?
|
Liposarcoma | 1 | 2017 | 289 | 0.110 |
Why?
|
Transcription Factors | 4 | 2018 | 12168 | 0.110 |
Why?
|
Tumor Suppressor Proteins | 4 | 2017 | 2810 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2022 | 4058 | 0.110 |
Why?
|
Sarcoma, Alveolar Soft Part | 1 | 2014 | 44 | 0.110 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2017 | 465 | 0.110 |
Why?
|
Lymphoma, T-Cell | 1 | 2016 | 308 | 0.110 |
Why?
|
Activin Receptors, Type I | 1 | 2014 | 134 | 0.110 |
Why?
|
Blotting, Southern | 3 | 2007 | 775 | 0.110 |
Why?
|
Vulvar Neoplasms | 1 | 2016 | 266 | 0.110 |
Why?
|
Child | 22 | 2025 | 80917 | 0.110 |
Why?
|
Cyclin E | 1 | 2013 | 155 | 0.110 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2021 | 1627 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 362 | 0.110 |
Why?
|
Bone Marrow | 1 | 2023 | 2935 | 0.110 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 498 | 0.110 |
Why?
|
Middle Aged | 36 | 2025 | 223492 | 0.110 |
Why?
|
Trans-Activators | 2 | 2013 | 2857 | 0.110 |
Why?
|
Colorectal Neoplasms | 3 | 2021 | 6974 | 0.100 |
Why?
|
Genes, Duplicate | 1 | 2012 | 31 | 0.100 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4580 | 0.100 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2019 | 5341 | 0.100 |
Why?
|
Multiprotein Complexes | 2 | 2016 | 1110 | 0.100 |
Why?
|
Adult | 33 | 2025 | 223646 | 0.100 |
Why?
|
Young Adult | 18 | 2025 | 60066 | 0.100 |
Why?
|
Isocitrate Dehydrogenase | 4 | 2025 | 951 | 0.100 |
Why?
|
Phosphoglycerate Dehydrogenase | 1 | 2011 | 38 | 0.090 |
Why?
|
Immunoconjugates | 2 | 2016 | 975 | 0.090 |
Why?
|
Homeodomain Proteins | 2 | 2018 | 2429 | 0.090 |
Why?
|
Smith-Magenis Syndrome | 1 | 2011 | 19 | 0.090 |
Why?
|
Gene Expression | 3 | 2016 | 7598 | 0.090 |
Why?
|
Child, Preschool | 13 | 2020 | 42669 | 0.090 |
Why?
|
Endometrial Neoplasms | 1 | 2020 | 1382 | 0.090 |
Why?
|
Chromosome Duplication | 1 | 2011 | 79 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 8 | 2016 | 18065 | 0.090 |
Why?
|
Gene Rearrangement | 5 | 2016 | 1146 | 0.090 |
Why?
|
Aged | 25 | 2025 | 171504 | 0.090 |
Why?
|
Parietal Lobe | 1 | 2016 | 866 | 0.090 |
Why?
|
Immunomagnetic Separation | 1 | 2010 | 78 | 0.090 |
Why?
|
Elafin | 1 | 2010 | 30 | 0.090 |
Why?
|
Urologic Neoplasms | 1 | 2014 | 314 | 0.090 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2016 | 1361 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3886 | 0.080 |
Why?
|
Neuroblastoma | 1 | 2018 | 1266 | 0.080 |
Why?
|
Telomerase | 1 | 2015 | 751 | 0.080 |
Why?
|
Genes, erbB-2 | 1 | 2010 | 162 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2016 | 1273 | 0.080 |
Why?
|
PTEN Phosphohydrolase | 5 | 2015 | 1120 | 0.080 |
Why?
|
Testicular Neoplasms | 1 | 2015 | 806 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 3 | 2023 | 5703 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2016 | 2062 | 0.080 |
Why?
|
High Mobility Group Proteins | 2 | 2000 | 179 | 0.080 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2010 | 78 | 0.080 |
Why?
|
MAP Kinase Signaling System | 2 | 2013 | 1494 | 0.080 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2009 | 165 | 0.080 |
Why?
|
Tissue Array Analysis | 4 | 2013 | 551 | 0.080 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2009 | 350 | 0.080 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2010 | 169 | 0.080 |
Why?
|
Adolescent | 17 | 2025 | 89169 | 0.080 |
Why?
|
Adenocarcinoma | 3 | 2019 | 6395 | 0.080 |
Why?
|
Nervous System Neoplasms | 1 | 2008 | 91 | 0.080 |
Why?
|
Chromosomes, Human, Pair 2 | 2 | 2007 | 313 | 0.070 |
Why?
|
Pituitary Neoplasms | 1 | 2016 | 1322 | 0.070 |
Why?
|
Patient Selection | 1 | 2020 | 4260 | 0.070 |
Why?
|
Aged, 80 and over | 12 | 2024 | 59629 | 0.070 |
Why?
|
Cell Lineage | 2 | 2014 | 2575 | 0.070 |
Why?
|
Tumor Cells, Cultured | 8 | 2013 | 6124 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4912 | 0.070 |
Why?
|
DNA Helicases | 2 | 2014 | 854 | 0.070 |
Why?
|
Survival Rate | 6 | 2025 | 12840 | 0.070 |
Why?
|
Gingival Hyperplasia | 1 | 2007 | 19 | 0.070 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 8542 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2907 | 0.070 |
Why?
|
Glycolysis | 1 | 2011 | 837 | 0.070 |
Why?
|
Diacylglycerol Kinase | 1 | 2007 | 47 | 0.070 |
Why?
|
Chromosome Mapping | 8 | 2008 | 4620 | 0.070 |
Why?
|
NFI Transcription Factors | 1 | 2007 | 49 | 0.070 |
Why?
|
Haploidy | 1 | 2007 | 127 | 0.070 |
Why?
|
DNA-Binding Proteins | 4 | 2015 | 9615 | 0.070 |
Why?
|
Serine Endopeptidases | 1 | 2012 | 1027 | 0.070 |
Why?
|
Hypertrichosis | 1 | 2007 | 31 | 0.070 |
Why?
|
Human Development | 1 | 2008 | 122 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1890 | 0.070 |
Why?
|
Disease Progression | 6 | 2019 | 13671 | 0.070 |
Why?
|
Sirolimus | 2 | 2014 | 1540 | 0.070 |
Why?
|
Apoptosis | 4 | 2016 | 9523 | 0.070 |
Why?
|
Reed-Sternberg Cells | 2 | 2018 | 78 | 0.070 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 1997 | 766 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2885 | 0.070 |
Why?
|
Genetic Loci | 1 | 2015 | 2629 | 0.070 |
Why?
|
Pheochromocytoma | 1 | 2008 | 328 | 0.070 |
Why?
|
Forkhead Transcription Factors | 1 | 2013 | 1625 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2010 | 564 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2016 | 12795 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2014 | 2892 | 0.060 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2010 | 681 | 0.060 |
Why?
|
Molecular Sequence Data | 7 | 2014 | 17622 | 0.060 |
Why?
|
Aneuploidy | 1 | 2009 | 573 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2021 | 10266 | 0.060 |
Why?
|
Neoplasms | 6 | 2017 | 22371 | 0.060 |
Why?
|
Cell Line, Tumor | 7 | 2020 | 17140 | 0.060 |
Why?
|
Congenital Abnormalities | 2 | 2008 | 703 | 0.060 |
Why?
|
Germ-Line Mutation | 2 | 2017 | 1885 | 0.060 |
Why?
|
Nervous System Malformations | 1 | 2007 | 243 | 0.060 |
Why?
|
Risk Assessment | 3 | 2025 | 24315 | 0.060 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2008 | 663 | 0.060 |
Why?
|
Infant | 8 | 2020 | 36535 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2020 | 3611 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2024 | 3800 | 0.060 |
Why?
|
Urogenital Abnormalities | 1 | 2007 | 255 | 0.060 |
Why?
|
Craniofacial Abnormalities | 1 | 2007 | 320 | 0.060 |
Why?
|
Seizures | 2 | 2007 | 2998 | 0.060 |
Why?
|
Hedgehog Proteins | 1 | 2008 | 771 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2016 | 2043 | 0.050 |
Why?
|
Genetic Markers | 3 | 2015 | 2603 | 0.050 |
Why?
|
Tissue Distribution | 3 | 2014 | 2300 | 0.050 |
Why?
|
Paraffin Embedding | 2 | 2017 | 307 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2015 | 5804 | 0.050 |
Why?
|
beta Catenin | 1 | 2008 | 1047 | 0.050 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2010 | 952 | 0.050 |
Why?
|
Cohort Studies | 8 | 2022 | 41754 | 0.050 |
Why?
|
Chromosomes, Human, Pair 14 | 2 | 2001 | 286 | 0.050 |
Why?
|
Ki-67 Antigen | 2 | 2016 | 630 | 0.050 |
Why?
|
Base Sequence | 5 | 2014 | 12421 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5863 | 0.050 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15454 | 0.050 |
Why?
|
Formaldehyde | 2 | 2017 | 362 | 0.050 |
Why?
|
Myometrium | 1 | 2003 | 174 | 0.050 |
Why?
|
Oncogenes | 1 | 2008 | 1234 | 0.050 |
Why?
|
Single-Cell Analysis | 1 | 2014 | 2540 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7454 | 0.050 |
Why?
|
Transplantation, Autologous | 2 | 2019 | 2120 | 0.050 |
Why?
|
Mice | 15 | 2023 | 82029 | 0.050 |
Why?
|
Signal Transduction | 5 | 2017 | 23645 | 0.050 |
Why?
|
Retrospective Studies | 8 | 2025 | 81762 | 0.050 |
Why?
|
Progestins | 1 | 2024 | 302 | 0.050 |
Why?
|
Animals | 18 | 2023 | 169246 | 0.050 |
Why?
|
Neoplasms, Adipose Tissue | 1 | 2001 | 12 | 0.050 |
Why?
|
Atrophy | 1 | 2007 | 1646 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2019 | 5717 | 0.050 |
Why?
|
Brain | 2 | 2007 | 27360 | 0.050 |
Why?
|
Genetic Variation | 1 | 2017 | 6611 | 0.050 |
Why?
|
Antigen Presentation | 2 | 2018 | 1251 | 0.050 |
Why?
|
Remission Induction | 2 | 2019 | 2410 | 0.050 |
Why?
|
Tumor Stem Cell Assay | 2 | 1998 | 116 | 0.050 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2014 | 2195 | 0.050 |
Why?
|
Internship and Residency | 1 | 2021 | 5953 | 0.050 |
Why?
|
Blotting, Western | 3 | 2010 | 5027 | 0.050 |
Why?
|
Hybrid Cells | 2 | 1998 | 421 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8054 | 0.050 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2001 | 192 | 0.050 |
Why?
|
Scoliosis | 1 | 2008 | 793 | 0.050 |
Why?
|
Syndrome | 3 | 2007 | 3272 | 0.040 |
Why?
|
Microsatellite Repeats | 2 | 2020 | 785 | 0.040 |
Why?
|
Family Health | 2 | 2008 | 1255 | 0.040 |
Why?
|
Mice, Nude | 4 | 2013 | 3623 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2025 | 39348 | 0.040 |
Why?
|
Growth Disorders | 1 | 2004 | 635 | 0.040 |
Why?
|
Molecular Biology | 1 | 2023 | 573 | 0.040 |
Why?
|
Scalp | 1 | 2022 | 391 | 0.040 |
Why?
|
Microarray Analysis | 1 | 2022 | 753 | 0.040 |
Why?
|
Neoplasm Transplantation | 2 | 2016 | 2014 | 0.040 |
Why?
|
Cell Proliferation | 5 | 2016 | 10474 | 0.040 |
Why?
|
South America | 1 | 2019 | 180 | 0.040 |
Why?
|
Glucose | 1 | 2011 | 4352 | 0.040 |
Why?
|
Oncogene Fusion | 1 | 2019 | 84 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2019 | 3590 | 0.040 |
Why?
|
Neurons | 2 | 2008 | 9514 | 0.040 |
Why?
|
Genotype | 4 | 2017 | 13045 | 0.040 |
Why?
|
Dystrophin | 1 | 2000 | 284 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2020 | 14729 | 0.040 |
Why?
|
Immunotherapy | 1 | 2014 | 4755 | 0.040 |
Why?
|
Steroids | 1 | 2024 | 938 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2019 | 3556 | 0.040 |
Why?
|
Face | 1 | 2004 | 1029 | 0.040 |
Why?
|
Glial Fibrillary Acidic Protein | 2 | 2012 | 563 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 2012 | 11101 | 0.040 |
Why?
|
Multigene Family | 2 | 2013 | 1081 | 0.040 |
Why?
|
DNA, Complementary | 2 | 2003 | 1989 | 0.040 |
Why?
|
Mice, SCID | 2 | 2016 | 2627 | 0.040 |
Why?
|
Certification | 1 | 2021 | 420 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2016 | 5196 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2002 | 832 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2011 | 615 | 0.040 |
Why?
|
Immunoprecipitation | 1 | 2020 | 874 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3803 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2008 | 3514 | 0.040 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2830 | 0.030 |
Why?
|
Algorithms | 2 | 2015 | 14164 | 0.030 |
Why?
|
Immunoblotting | 1 | 2020 | 1647 | 0.030 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 431 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1998 | 1057 | 0.030 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 1997 | 378 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 11878 | 0.030 |
Why?
|
Mechlorethamine | 1 | 2016 | 129 | 0.030 |
Why?
|
RNA, Messenger | 3 | 2002 | 12800 | 0.030 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2016 | 83 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2020 | 614 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1228 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2016 | 21206 | 0.030 |
Why?
|
World Health Organization | 1 | 2022 | 1329 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 2 | 2010 | 2474 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2008 | 2333 | 0.030 |
Why?
|
Thyroid Neoplasms | 1 | 2009 | 2360 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2016 | 267 | 0.030 |
Why?
|
Pregnancy | 2 | 2022 | 30256 | 0.030 |
Why?
|
Leukemia, Myeloid | 1 | 1998 | 693 | 0.030 |
Why?
|
Time Factors | 4 | 2019 | 40218 | 0.030 |
Why?
|
Stem Cells | 1 | 2008 | 3537 | 0.030 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2019 | 594 | 0.030 |
Why?
|
Bleomycin | 1 | 2016 | 492 | 0.030 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1997 | 414 | 0.030 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 1997 | 458 | 0.030 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2018 | 335 | 0.030 |
Why?
|
Vinblastine | 1 | 2016 | 487 | 0.030 |
Why?
|
Mycosis Fungoides | 1 | 2016 | 169 | 0.030 |
Why?
|
Etoposide | 1 | 2016 | 639 | 0.030 |
Why?
|
Educational Measurement | 1 | 2021 | 1260 | 0.030 |
Why?
|
Retreatment | 1 | 2016 | 598 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6847 | 0.030 |
Why?
|
Pineal Gland | 1 | 2015 | 158 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2017 | 592 | 0.030 |
Why?
|
Human Genome Project | 2 | 2008 | 202 | 0.030 |
Why?
|
STAT Transcription Factors | 1 | 2014 | 189 | 0.030 |
Why?
|
Caspase 3 | 1 | 2016 | 730 | 0.030 |
Why?
|
Rabbits | 1 | 2020 | 4772 | 0.030 |
Why?
|
Smad Proteins | 1 | 2014 | 157 | 0.030 |
Why?
|
Vincristine | 1 | 2016 | 1040 | 0.030 |
Why?
|
GTP Phosphohydrolases | 1 | 1997 | 525 | 0.030 |
Why?
|
Janus Kinases | 1 | 2014 | 253 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2018 | 13014 | 0.030 |
Why?
|
Paired Box Transcription Factors | 1 | 2014 | 206 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3623 | 0.030 |
Why?
|
Phosphorylation | 2 | 2016 | 8317 | 0.030 |
Why?
|
RNA, Neoplasm | 2 | 2010 | 749 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3436 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 2015 | 393 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3212 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2008 | 4362 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2661 | 0.030 |
Why?
|
Genetic Counseling | 1 | 2016 | 635 | 0.020 |
Why?
|
Genomic Instability | 1 | 2016 | 716 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2014 | 663 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2016 | 2909 | 0.020 |
Why?
|
3T3 Cells | 1 | 2013 | 1084 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 905 | 0.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2010 | 5432 | 0.020 |
Why?
|
Amino Acid Sequence | 3 | 1998 | 13421 | 0.020 |
Why?
|
Prednisone | 1 | 2016 | 1567 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 325 | 0.020 |
Why?
|
Survival Analysis | 2 | 2017 | 10101 | 0.020 |
Why?
|
Treatment Outcome | 5 | 2018 | 65371 | 0.020 |
Why?
|
Neurofibromin 1 | 1 | 2012 | 190 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2017 | 6082 | 0.020 |
Why?
|
RNA Interference | 2 | 2010 | 2832 | 0.020 |
Why?
|
Eye Proteins | 1 | 2014 | 628 | 0.020 |
Why?
|
Prospective Studies | 3 | 2025 | 54926 | 0.020 |
Why?
|
Down-Regulation | 1 | 1997 | 2937 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20227 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2017 | 16045 | 0.020 |
Why?
|
Doxorubicin | 1 | 2016 | 2234 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 710 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2017 | 2359 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2014 | 845 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 8 | 1 | 2008 | 49 | 0.020 |
Why?
|
Exons | 1 | 2014 | 2394 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 317 | 0.020 |
Why?
|
Hirsutism | 1 | 2008 | 68 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2010 | 412 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 1997 | 4833 | 0.020 |
Why?
|
Cell Line | 3 | 2008 | 15597 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 942 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2015 | 2732 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 4 | 2016 | 36743 | 0.020 |
Why?
|
Antigens, CD1 | 1 | 2010 | 434 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2012 | 1245 | 0.020 |
Why?
|
Quinazolines | 1 | 2014 | 1373 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2016 | 2451 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2008 | 752 | 0.020 |
Why?
|
Cerebrum | 1 | 2008 | 132 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2010 | 858 | 0.020 |
Why?
|
Cell Survival | 2 | 2010 | 5777 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2016 | 2457 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2008 | 13586 | 0.020 |
Why?
|
DNA Repair | 1 | 2016 | 2050 | 0.020 |
Why?
|
Tretinoin | 1 | 1990 | 524 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2008 | 1305 | 0.020 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2008 | 361 | 0.020 |
Why?
|
Transfection | 2 | 2009 | 5755 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2008 | 3610 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2014 | 1596 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3772 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2008 | 320 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6316 | 0.020 |
Why?
|
Clinical Competence | 1 | 2021 | 4858 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2010 | 1743 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2010 | 1837 | 0.020 |
Why?
|
United States | 3 | 2021 | 73039 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2014 | 2885 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2008 | 1703 | 0.020 |
Why?
|
Calcium Channels, L-Type | 1 | 2007 | 244 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5505 | 0.020 |
Why?
|
Protein Kinase C | 1 | 1990 | 1207 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 1754 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3445 | 0.010 |
Why?
|
Ureter | 1 | 2007 | 364 | 0.010 |
Why?
|
Pneumonia | 1 | 2016 | 2163 | 0.010 |
Why?
|
Hepatitis B, Chronic | 1 | 2008 | 413 | 0.010 |
Why?
|
Myocardium | 1 | 1997 | 4788 | 0.010 |
Why?
|
DNA Primers | 1 | 2008 | 2828 | 0.010 |
Why?
|
Chromosome Fragility | 1 | 2003 | 16 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5797 | 0.010 |
Why?
|
Chromosome Fragile Sites | 1 | 2003 | 26 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 2 | 1998 | 2748 | 0.010 |
Why?
|
Genes, Overlapping | 1 | 2003 | 36 | 0.010 |
Why?
|
Euchromatin | 1 | 2003 | 54 | 0.010 |
Why?
|
Pseudogenes | 1 | 2003 | 104 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1406 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6526 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2016 | 4937 | 0.010 |
Why?
|
Culture Techniques | 1 | 2003 | 530 | 0.010 |
Why?
|
Expressed Sequence Tags | 1 | 2003 | 251 | 0.010 |
Why?
|
Wnt Proteins | 1 | 2007 | 725 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22291 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 1143 | 0.010 |
Why?
|
Limb Deformities, Congenital | 1 | 2003 | 136 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8509 | 0.010 |
Why?
|
Pilot Projects | 1 | 2015 | 8741 | 0.010 |
Why?
|
Retroelements | 1 | 2003 | 162 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6894 | 0.010 |
Why?
|
Gene Duplication | 1 | 2003 | 315 | 0.010 |
Why?
|
Administration, Oral | 1 | 2010 | 4030 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2013 | 3703 | 0.010 |
Why?
|
Transplantation, Heterologous | 2 | 1995 | 2393 | 0.010 |
Why?
|
Radiation Hybrid Mapping | 1 | 2001 | 18 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6211 | 0.010 |
Why?
|
Sequence Tagged Sites | 1 | 2001 | 96 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2007 | 1676 | 0.010 |
Why?
|
Genomic Imprinting | 1 | 2003 | 326 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2007 | 1327 | 0.010 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2001 | 125 | 0.010 |
Why?
|
Williams Syndrome | 1 | 2003 | 195 | 0.010 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2008 | 1247 | 0.010 |
Why?
|
Risk Factors | 2 | 2019 | 74944 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1990 | 2433 | 0.010 |
Why?
|
Chromosomes, Human, 6-12 and X | 1 | 2000 | 69 | 0.010 |
Why?
|
Hepatitis C, Chronic | 1 | 2008 | 1032 | 0.010 |
Why?
|
Prostate-Specific Antigen | 1 | 2010 | 2463 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3428 | 0.010 |
Why?
|
DNA Methylation | 1 | 2014 | 4428 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12543 | 0.010 |
Why?
|
Spinal Cord | 1 | 2007 | 1811 | 0.010 |
Why?
|
Origin Recognition Complex | 1 | 1998 | 20 | 0.010 |
Why?
|
Replication Origin | 1 | 1998 | 77 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5902 | 0.010 |
Why?
|
CpG Islands | 1 | 2003 | 1208 | 0.010 |
Why?
|
Lung | 1 | 1997 | 10099 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 1998 | 525 | 0.010 |
Why?
|
Fibroblasts | 1 | 2007 | 4176 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2003 | 1758 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4413 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 1997 | 697 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2015 | 26422 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2008 | 7608 | 0.010 |
Why?
|
Autistic Disorder | 1 | 2003 | 1240 | 0.010 |
Why?
|
Alternative Splicing | 1 | 1998 | 1105 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1998 | 4168 | 0.010 |
Why?
|
RNA | 1 | 2003 | 2720 | 0.010 |
Why?
|
Kidney | 1 | 2007 | 7064 | 0.010 |
Why?
|
DNA Replication | 1 | 1998 | 1427 | 0.010 |
Why?
|
Electroencephalography | 1 | 2007 | 6314 | 0.010 |
Why?
|
Computational Biology | 1 | 2003 | 3568 | 0.010 |
Why?
|
Cell Cycle | 1 | 1998 | 2932 | 0.010 |
Why?
|
Glycoconjugates | 1 | 1990 | 88 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 22379 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1990 | 826 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18349 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2010 | 20760 | 0.000 |
Why?
|
Drug Synergism | 1 | 1990 | 1760 | 0.000 |
Why?
|
DNA | 1 | 1997 | 7214 | 0.000 |
Why?
|
Age Factors | 1 | 1999 | 18412 | 0.000 |
Why?
|
Cell Division | 1 | 1990 | 4473 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1997 | 19015 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1990 | 10760 | 0.000 |
Why?
|